AstraZeneca reaches 2bn capacity for coronavirus vaccine doses, receives more funds from Bill Gates’ organisation

AstraZeneca PLC has doubled capacity to 2bn doses of coronavirus (COVID-19) vaccine after fresh funding from Bill Gates’ organisation.

Late on Thursday, the FTSE 100-listed firm signed a US$750mln deal with global vaccine organisations CEPI (part of the Bill & Melinda Gates Foundation) and Gavi to deliver 300mln doses at the end of the year.

It also reached a licensing agreement with the Serum Institute of India to supply 1bn doses for low-and-middle-income countries.

We are primarily funded by readers. Please subscribe and donate to support us!

www.proactiveinvestors.co.uk/companies/amp/news/921259?__twitter_impression=true

 

Tess

Views:

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.